The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI.
Bourgeois. Benjamin B; Spreitzer. Emil E; Platero-Rochart. Daniel D; Paar. Margr...
Scientists discovered that the anti‑aging peptide FOXO4‑DRI sticks to a part of the p53 protein that’s usually floppy, and this binding helps kill old, senescent cells. The peptide works best when p53 is phosphorylated, and the study maps out exactly how the two molecules fit together.